None have been approved by the Food and Drug Administration so far, though in 2019, Johnson & Johnson received FDA permission ...

BPL-003 showed “robust” efficacy data in treatment-resistant depression, according to analysts from Jefferies, who noted that ...

A psychedelic nasal spray requiring a much shorter period of clinical supervision has shown promise against ...

Positive study results in Phase 2 lead to a green light for the companies’ combination and plans to move their nasal spray ...

As respiratory illnesses like COVID-19, influenza, and Mycoplasma pneumonia continue to spread, the need for safe, ...